Tumor
Conditions
Interventions
trial group:Take Huisheng oral liquid in perioperative period
control group:Without any anticoagulant therapy in perioperative period
Sponsors
The forth hospital of Hebei Medical University
Eligibility
Sex/Gender
All
Age
18 Years to 69 Years
Inclusion criteria
Inclusion criteria: 1. Satisfy the primary lung cancer diagnostic criteria; 2. Have the surgical indications; 3. Aged 18~69 years, all genders; 4. The score of ECOG 0~2; 5. Expected lifetime >=3 months; 6. No components allergies; 7. No DVT, PE, stroke, AMI histories; 8. No acute spinal cord injury, joint replacement and multiple trauma of hip joint, pelvis or lower limb fracture in 1 month.
Exclusion criteria
Exclusion criteria: 1. Unsatisfy the primary lung cancer diagnostic criteria; 2. No surgical indications; 3. Allergy sufferer, or used to have severe allergic reactions; 4. Have DVT, PE, stroke, AMI histories; 5. Have acute spinal cord injury, joint replacement and multiple trauma of hip joint, pelvis or lower limb fracture in 1 month; 6. Have uncontrolled nerve or mental diseases; Poor compliance or unable to communicate; Have primary brain tumor or central neurocytoma; 7. Participate other clinical trials; 8. Have other situations that unsuitable for this trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood routine test;PT;APTT;TT;FIB;D-Dimer;AT-III;Protein-C; | — |
Secondary
| Measure | Time frame |
|---|---|
| routine urine test;liver function test;kidney function test; | — |
Countries
China
Contacts
Public ContactGuo Yang
Outcome results
None listed